Feiba NF 3250 Unit

FEIBA NF 3250 Unit is an anti-inhibitor coagulant complex used for managing bleeding episodes in patients with hemophilia. This intravenous kit contains 3250 units per 50mL, manufactured by Takeda Canada Inc.

FEIBA NF 3250 Unit is primarily used to control bleeding in individuals with hemophilia who have developed inhibitors to standard treatments. It is designed to help manage bleeding episodes by providing clotting factors. This medication is often used when other treatments are ineffective due to the presence of inhibitors.

Common effects of FEIBA NF 3250 Unit may include localized reactions at the injection site, such as redness or swelling. Some users may experience systemic reactions like fever or chills. As with any intravenous medication, there is a risk of allergic reactions, which should be monitored closely.

FEIBA NF 3250 Unit should be administered under medical supervision to ensure proper handling and dosage. Patients with a history of allergic reactions to similar products should use this medication with caution. It is important to follow all safety guidelines provided by healthcare professionals.

FEIBA NF 3250 Unit may interact with other medications that affect blood clotting. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of this medication.